Form 4: PetVivo CFO Garry Lowenthal Acquires 66,421 Shares

Sentiment:

Statement of Changes in Beneficial Ownership


PetVivo Holdings CFO Garry Lowenthal received a grant of 66,421 shares of common stock as compensation for past performance.

Summary

  • Garry Lowenthal, Chief Financial Officer of PetVivo Holdings, Inc., acquired 66,421 shares of common stock.
  • The transaction occurred on May 15, 2026, at a price of $0.72 per share.
  • The shares were granted to a corporation owned by the reporting person as compensation for past performance.
  • Following this transaction, the reporting person beneficially owns 878,881 shares indirectly through a corporation.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it reflects management's continued commitment to the company through equity ownership.

Positives

  • Insider acquisition of company stock demonstrates alignment between management and shareholder interests.
  • The grant serves as compensation for past performance, indicating recognition of the executive's contributions.

Negatives

  • The transaction represents a non-cash compensation event, which may impact future equity dilution.

Risks

  • Reliance on equity-based compensation may increase share count and dilute existing shareholders.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Management Comments

  • The grant of restricted common stock was issued as compensation for the reporting person's past performance.

Industry Context

StockSavvy.ai notes that executive equity grants are standard practice in the biotechnology and medical device sectors to preserve cash while incentivizing leadership performance.

Comparison to Industry Standards

  • Equity-based compensation for C-suite executives is consistent with standard practices for small-cap growth companies.
  • The use of restricted stock grants aligns with typical retention strategies in the life sciences industry.

Related Party Transactions

  • The shares were granted to a corporation owned by the reporting person.

Stakeholder Impact

  • Shareholders may experience minor dilution due to the issuance of new restricted stock.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
05/15/2026Date of the stock grant transaction.
05/18/2026Date of the filing signature.

Keywords

PetVivo Holdings, PETV, Insider Trading, Form 4, CFO, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.